ライフサイエンスコーパス: sex hormone-binding globulin

1 one sulfate, androstanediol glucuronide, and sex hormone binding globulin).

2 Both drugs bind to sex hormone binding globulin.

3 te (GFR), testosterone, androstenedione, and sex hormone binding globulin.

4 vel of steroid sex hormone or a low level of sex hormone binding globulin.

5 ved at the plasma membrane by a receptor for sex hormone-binding globulin.

6 m, including adiponectin, triglycerides, and sex hormone-binding globulin.

7 d by hormonal contraceptives and mediated by sex hormone-binding globulin.

8 s were assayed for estrogens, androgens, and sex hormone-binding globulin.

9 rostane-3alpha, 17beta-diol-glucuronide, and sex hormone-binding globulin.

10 ficant for several estrogens, androgens, and sex hormone-binding globulin (2-sided P <or= 0.01).

11 follicle-stimulating hormone, estradiol, and sex hormone-binding globulin-adjusted estradiol (free es

12 l: 0.01, 0.03) and inverse associations with sex hormone-binding globulin and follicle-stimulating ho

13 Sex hormone-binding globulin and high-density lipoprotei

14 The G domains are related to those found in sex hormone-binding globulin and to those utilized by la

15 with hyperandrogen, with obesity, with high-sex hormone-binding globulin and with high-luteinizing h

16 ing serum levels of testosterone, estradiol, sex hormone binding globulin, and androstenediol glucuro

17 roportion of variability (6% after fat mass, sex hormone binding globulin, and insulin levels were ad

18 ere independent of age, plasma estradiol and sex hormone binding globulin, and were highly consistent

19 There were no differences in testosterone, sex hormone-binding globulin, and blood lipids between t

20 ucose, insulin, C-peptide, 17beta-estradiol, sex hormone-binding globulin, and IL-4.

21 negatively associated with concentrations of sex-hormone binding globulin, and positively associated

22 Low circulating levels of sex hormone-binding globulin are a strong predictor of t

23 e, hepatocyte growth factor-like protein and sex hormone-binding globulin as potential mediators of t

24 gnificant differences in total estradiol and sex hormone binding globulin at the completion of the in

25 minase (beta = 0.002; P = 3 x 10(-5)), lower sex-hormone-binding globulin (beta = -0.010; P = 9 x 10(

26 mproved and levels of C-reactive protein and sex hormone-binding globulin but not interleukin-6 incre

27 2 pmol per liter) (P = 0.009), and the serum sex hormone-binding globulin concentration increased fro

28 (decreased blood concentration and increased sex hormone-binding globulin concentration).

29 in resistance (P=6 x 10(-4)) and lower serum sex hormone binding globulin concentrations (P=5 x 10(-4

30 ble serum estradiol concentrations and serum sex hormone-binding globulin concentrations of 1 microg

31 y study that provides multivariably adjusted sex hormone-binding globulin data indicates that this bi

32 highest PCOS remission rate; PCOS with high-sex hormone-binding globulin demonstrated favorable repr

33 rexophilin-1 and the second laminin/neurexin/sex-hormone-binding globulin domain (LNS2) of neurexin-1

34 ween the fifth LNS (laminin-alpha, neurexin, sex hormone-binding globulin) domain and the third EGF-l

35 the single LNS-domain (for laminin/neurexin/sex hormone-binding globulin-domain) of neurexin-1beta o

36 ostenedione, dehydroepiandrosterone sulfate, sex hormone-binding globulin, estrone, estradiol, C-pept

37 izing hormone, follicle-stimulating hormone, sex hormone-binding globulin, F(2)-isoprostanes, and thi

38 Serum testosterone, estradiol, sex hormone binding globulin, gonadotropins, and bone de

39 centrations and high serum concentrations of sex hormone-binding globulin have an increased risk of h

40 ke with endogenous androgens, estrogens, and sex hormone-binding globulin in 728 white postmenopausal

41 serum testosterone in male subjects and the sex hormone-binding globulin in both groups.

42 Serum sex hormone binding globulin increased and leptin decrea

43 riol, testosterone, progesterone, prolactin, sex hormone binding globulin, insulin-like growth factor

44 Total-body BMD, sex hormone binding globulin, leptin, and estrone were m

45 Demented women had higher mean serum sex hormone binding globulin levels than nondemented wom

46 ide polymorphism (SNP) rs6259 had 10% higher sex hormone-binding globulin levels (P=0.005), and carri

47 rve (SUV(AUC,WB)); and SUV(BW) corrected for sex hormone-binding globulin levels (SUV(SHBG)).

48 Circulating sex hormone-binding globulin levels are inversely associ

49 A dramatic 45-fold increase in sex hormone-binding globulin levels during hibernation d

50 free testosterone (FT) levels decreased and sex hormone-binding globulin levels increased in tandem

51 Estradiol, estrone, and sex hormone-binding globulin levels increased in the est

52 Testosterone, estradiol, and sex hormone-binding globulin levels were measured in ser

53 Sex hormone-binding globulin levels were positively asso

54 and ATG4Btranscriptomic regulation and with sex hormone-binding globulin levels.

55 directions corresponding to their associated sex hormone-binding globulin levels.

56 analogs, we demonstrated that the C terminus sex hormone-binding globulin-like (SHBG) domain of PS is

57 d residues on the pentraxin/laminin-neurexin-sex-hormone-binding-globulin-like (PLL) domain of GPR56

58 main that we term Pentraxin/Laminin/neurexin/sex-hormone-binding-globulin-Like (PLL).

59 ins are largely composed of laminin-neurexin-sex hormone-binding globulin (LNS)/laminin G domains, wh

60 by gamma-glutamyltransferase, fetuin-A, and sex hormone-binding globulin), markers of dyslipidemia (

61 .58) among men, a finding that suggests that sex hormone-binding globulin may have a causal role in t

62 of PCOS (obesity, elevated testosterone, low sex hormone binding globulin) may explain the associatio

63 strone, progesterone, free testosterone, and sex hormone binding globulin measurements.

64 ; positive associations for progesterone and sex hormone binding globulin merit additional study.

65 l pathways of cardiovascular disease, and of sex hormone-binding globulin on type 2 diabetes.

66 CI: 1.12, 1.68; P = 0.002) and a decrease in sex hormone-binding globulin (OR = 0.60, 95% CI: 0.45, 0

67 peptide (NT-proBNP), total testosterone, and sex hormone-binding globulin plasma levels in 4,056 men

68 xcess, hyperinsulinemia, and reduced hepatic sex hormone-binding globulin production create a self-su

69 e (r = 0.37)) and negatively correlated with sex hormone-binding globulin (r = -0.48).

70 ree androgen index (FAI) (total testosterone/sex hormone-binding globulin ratio).

71 ation of known and unknown recombinant human sex hormone-binding globulin (rhSHBG)-binding designer s

72 sport proteins human serum albumin (HSA) and sex hormone binding globulin (SHBG) as models.

73 ia receptors for the steroid-binding protein sex hormone binding globulin (SHBG) by attempting to blo

74 Testosterone, estradiol, and sex hormone binding globulin (SHBG) concentrations were

75 In the sex hormone binding globulin (SHBG) gene, a pentanucleot

76 Sex hormone binding globulin (SHBG) is found in the brai

77 We measured testosterone, estradiol, and sex hormone binding globulin (SHBG) levels and calculate

78 l studies consistently show that circulating sex hormone binding globulin (SHBG) levels are lower in

79 hether prediagnostic circulating hormone and sex hormone binding globulin (SHBG) levels were associat

80 hether prediagnostic circulating hormone and sex hormone binding globulin (SHBG) levels were associat

81 rized by higher luteinizing hormone (LH) and sex hormone binding globulin (SHBG) levels with relative

82 teins, but there is evidence that binding to sex hormone binding globulin (SHBG) might enhance tumor

83 was the effect of the baseline oestradiol to sex hormone binding globulin (SHBG) ratio (oestradiol-SH

84 Correspondingly, sex hormone binding globulin (SHBG) which lowers circula

85 these agents for PET imaging is needed since sex hormone binding globulin (SHBG), a glycoprotein whic

86 obank was strongly associated with levels of sex hormone binding globulin (SHBG), a key regulator of

87 ne, dehydroepiandrosterone sulfate (DHEAS)], sex hormone binding globulin (SHBG), and EOC risk by tum

88 en was associated with serum sex steroids or sex hormone binding globulin (SHBG).

89 ) and free PSA%, as well as higher levels of sex hormone binding globulin (SHBG).

90 e (FT), bioavailable testosterone (BAT), and sex hormone binding globulin (SHBG).

91 ncentrations of all other lipid moieties and sex hormone binding globulin (SHBG).

92 owever, after including % estradiol bound to sex hormone-binding globulin (SHBG) and total estradiol

93 (nAPCsr) and to thrombomodulin (nTMsr), with sex hormone-binding globulin (SHBG) as a secondary end p

94 away from estrogens and toward androgens and sex hormone-binding globulin (SHBG) as potential mediato

95 It is known that unliganded sex hormone-binding globulin (SHBG) binds to a receptor

96 one, free testosterone, androstenedione, and sex hormone-binding globulin (SHBG) concentrations (seco

97 lored associations of total testosterone and sex hormone-binding globulin (SHBG) concentrations at ag

98 ne and week 12 serum estradiol, estrone, and sex hormone-binding globulin (SHBG) concentrations were

99 Sex hormone-binding globulin (SHBG) determines the equil

100 , androstanediol glucuronide, estradiol, and sex hormone-binding globulin (SHBG) for 3,043 cases and

101 hydroepiandrosterone sulfate, prolactin, and sex hormone-binding globulin (SHBG) improved risk predic

102 concentrations of estrogens, androgens, and sex hormone-binding globulin (SHBG) in a population-base

103 ormones such as estradiol, testosterone, and sex hormone-binding globulin (SHBG) in the etiology of l

104 Sex hormone-binding globulin (SHBG) is a circulating gly

105 Sex hormone-binding globulin (SHBG) is a plasma protein

106 Sex hormone-binding globulin (SHBG) is an important regu

107 Sex hormone-binding globulin (SHBG) is believed to play

108 Sex hormone-binding globulin (SHBG) is the high-affinity

109 Low plasma sex hormone-binding globulin (SHBG) levels are associate

110 ine increased and significantly decreased as sex hormone-binding globulin (SHBG) levels at follow-up

111 (LH), follicle-stimulating hormone (FSH) and sex hormone-binding globulin (SHBG) levels were measured

112 ions of anti-Mullerian hormone (AMH) levels, sex hormone-binding globulin (SHBG) levels, menopause ag

113 reast cancer risk by stimulating circulating sex hormone-binding globulin (SHBG) levels.

114 ne whether plasma levels of sex hormones and sex hormone-binding globulin (SHBG) may account for the

115 concentrations of estrogens, androgens, and sex hormone-binding globulin (SHBG) was investigated in

116 udy were analyzed to examine whether ESH and sex hormone-binding globulin (SHBG) were associated with

117 serum concentrations of total testosterone, sex hormone-binding globulin (SHBG), dehydroepiandroster

118 Independent variables were testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone

119 rs and concentrations of total testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone

120 a are available regarding the association of sex hormone-binding globulin (SHBG), testosterone, and t

121 with participants in the lowest quartile of sex hormone-binding globulin (SHBG), those in the highes

122 dy was to investigate the associations among sex hormone-binding globulin (SHBG), visceral adipose ti

123 ating hormone (FSH), total testosterone, and sex hormone-binding globulin (SHBG), were performed in 6

124 t-specific 6 chimeras, with either the whole sex hormone-binding globulin (SHBG)-like domain (Val243-

125 nent to circulating sex steroid hormones and sex hormone-binding globulin (SHBG).

126 inverse relations between serum insulin and sex hormone-binding globulin (SHBG).

127 l and free testosterone (TT and FT) and high sex hormone-binding globulin (SHBG).

128 rations of high-density lipoprotein (9%) and sex-hormone binding globulin (SHBG) (21%), and lower con

129 Sex-hormone binding globulin (SHBG) was associated inver

130 Mean plasma concentrations of total and sex-hormone-binding-globulin (SHBG)-bound testosterone w

131 ured; two polymorphisms of the gene encoding sex hormone-binding globulin, SHBG, that were robustly a

132 ata demonstrate that higher androgens, lower sex hormone-binding globulin, surgical menopause, and ea

133 Serum concentrations of sex hormone-binding globulin that were 1.0 microg per de

134 -estradiol, the ratio of 17beta-estradiol to sex hormone-binding globulin, the fasting insulin resist

135 Polygenic scores associated with sex hormone binding globulin, vitamin D, and total chole

136 unassociated with cognitive composites, but sex hormone binding globulin was positively associated w

137 rd-deviation increase in the plasma level of sex hormone-binding globulin was 0.28 (95% CI, 0.13 to 0

138 Sex hormone-binding globulin was determined by immunoass

139 Sex hormone-binding globulin was directly associated wit

140 eptin, and C-reactive protein were lower and sex hormone-binding globulin was higher in the low-prote

141 e sulfate, follicle-stimulating hormone, and sex hormone-binding globulin were measured.

142 Plasma levels of sex hormone-binding globulin were measured; two polymorp

143 Among women, higher plasma levels of sex hormone-binding globulin were prospectively associat

144 Other antiepileptic drugs increase sex hormone-binding globulin, which reduces the bioactiv

145 irculating levels of 25-hydroxyvitamin D and sex hormone binding globulin with ovarian cancer or its

146 es in the Laminin A G domain, Neurexins, and Sex hormone-binding globulin, with three interspersed ep